InvestorsHub Logo
Followers 3
Posts 114
Boards Moderated 0
Alias Born 10/02/2017

Re: None

Tuesday, 08/07/2018 9:54:02 PM

Tuesday, August 07, 2018 9:54:02 PM

Post# of 2001
“Investigator-initiated Phase II Clinical Study of Remetinostat Started in Patients With Basal Cell Carcinoma”
This was released a few days ago. Zero discussion here. In my opinion, with all the positive momentum, it’s bizarre the price per share is under a dollar. Still long and haven’t sold any shares.

https://www.prnewswire.com/news-releases/investigator-initiated-phase-ii-clinical-study-of-remetinostat-started-in-patients-with-basal-cell-carcinoma-300690987.html